CD44 and breast carcinoma: ZFHX3 also enhanced breast cancer stemness, as indicated by ZFHX3-induced increases in mammosphere formation and the populations of ALDH+ or CD44+/CD24− cells (Figure 2), and cancer stemness is crucial for tumor initiation and progression.